rHEALTH ONE Blood Analyzers Delivered to NASA for International Space Station

CAMBRIDGE, Mass., September 30, 2019rHEALTH LLC and its affiliate DNA Medicine Institute, Inc. announced today that rHEALTH ONE blood analyzers have been delivered to NASA and its prime contractor Zin Technologies for spaceflight qualification. The analyzers will undergo rigorous testing under NASA’s International Space Station Commercial-Off-The-Shelf (COTS) Certification Process Work Instruction, ensuring they meet payload verification, safety, and quality standards.

“This is an exciting milestone for the rHEALTH technology,” said Dr. Eugene Chan, CEO. “We have worked closely with NASA to develop a small-volume blood analysis system for space, with dual-use applications in homes and clinical settings. This technology empowers astronauts—and individuals everywhere—to diagnose themselves safely and accurately, under the most demanding conditions.”

The rHEALTH ONE is a compact cytometry-based blood analyzer that uses tiny blood samples (<10 μL). At 1.5 kg, it is lighter than most laptops and draws minimal power (<2.5 W) from a single USB port. Its optical module and sample loading system have been successfully tested in zero-gravity parabolic flights with NASA. The device analyzes cells and rHEALTH’s nanoscale test strips in a multiplexed format, delivering results in minutes.

About rHEALTH®
rHEALTH develops and commercializes its Diagnose Yourself, Anywhere™ technology. Its innovations include:

  • rHEALTH Diagnostic Platform – enabling multiple laboratory tests from a single small-volume blood sample at the point-of-care.

  • SKYE Sensor – a wireless wearable providing comprehensive real-time vital signs monitoring.

  • CHAS – a user-friendly mobile application supporting health management.

For more information, visit www.rhealth.com.

About DNA Medicine Institute
DNA Medicine Institute (DMI) is a biomedical incubator advancing patient care, alleviating human suffering, and treating disease through innovation. Its work is supported by NASA, NIH, and the Bill & Melinda Gates Foundation, leveraging interdisciplinary science and engineering expertise to solve challenging problems.

For more information, visit www.dnamedinstitute.com.

Media Contact:
Rebecca Yu
(617) 913-7630
pr@rhealth.com

Previous
Previous

Abstracts for rHEALTH’s Factor VIII and Platelet Tests Accepted for Poster and Oral Presentations at Upcoming AACC 2019 Meeting

Next
Next

rHEALTH FVIII Solution to be Presented at WFH’s 11th Global Forum